Join us for this exciting annual meeting on advanced imaging and clinical strategies for managing heart failure. This event continues the collaboration between the British Society of Echocardiography and the Royal Society of Medicine, and this year, it is also organised in association with the British Society for Heart Failure.
Looking ahead, sessions will highlight cutting-edge imaging for phenotyping Heart failure with preserved ejection fraction (HFpEF), pulmonary hypertension, and amyloidosis. A keynote lecture on the future of heart failure treatment will also be presented. The day concludes with a multidisciplinary team discussion featuring real-world cases, offering actionable insights for improved patient outcomes.
By attending this event, you will learn:
- Advanced imaging's role in cardiogenic shock, transplant assessment, CRT optimisation, and guiding interventions for valvular heart failure
- HFpEF as the "new pandemic"
- The interplay with atrial myopathy, and identifying elevated filling pressures in atrial fibrillation.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors Alnylam, AstraZeneca, Bracco, Edward Lifesciences, GE Healthcare, MSD, Pfizer and Philips who have provided sponsorship towards this independent programme. None of the companies listed have had editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence.
This event has also been supported by a financial grant from Bayer Plc. Bayer Plc has had no involvement whatsoever in the development or implementation of the event.